We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MQ:NASDAQMarqeta, Inc. Analysis

Data as of 2026-05-19 - not real-time

$3.94

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The 20‑day moving average sits just above the 50‑day average, indicating a modest upward bias, while the 200‑day average remains higher, keeping the longer‑term trend neutral. The RSI hovers in the low‑40s, suggesting limited downside pressure but no overbought condition. MACD shows a bearish histogram and the signal line is below the MACD line, reinforcing short‑term bearish momentum. Price is trading near a key support level around $3.77 with resistance near $4.65, and the recent increase in volume points to heightened market participation. Volatility over the past 30 days is elevated, exceeding 40%, and the stock has experienced a steep max drawdown of over 40% in its history, highlighting the risk of sharp moves. The beta of roughly 0.8 suggests the stock moves less than the broader market, offering some defensive characteristics despite sector turbulence.
Fundamentally, the company delivered a strong quarter, beating revenue expectations with high‑double‑digit growth and posted a surprise profit, which has fueled optimism ahead of the upcoming earnings release. Management projects GAAP net income in the mid‑single‑digit millions for the year and maintains a 12‑14% net revenue growth outlook, complemented by robust transaction volume expansion. The balance sheet is solid, with cash far exceeding debt, and free cash flow remains healthy. However, the trailing P/E of nearly 400 dwarfs the industry average, reflecting the current earnings base rather than future potential. A discounted cash flow model implies a fair value around $9.5, indicating a sizable upside from the current price. The fear‑and‑greed index is in the “Extreme Greed” zone, suggesting bullish sentiment may be overstretched. Overall, the stock presents a blend of growth promise and valuation challenges.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish MACD momentum
  • Elevated short‑term volatility and upcoming earnings catalyst
  • Increasing volume indicating active trading interest

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and emerging profitability
  • DCF‑derived upside potential exceeding 30%
  • Robust cash position supporting continued investment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term tailwinds in digital card issuance and BNPL integration
  • Competitive positioning in a high‑growth fintech infrastructure niche
  • Execution risk from market competition and regulatory environment

Key Metrics & Analysis

Financial Health

Revenue Growth19.20%
Profit Margin0.33%
P/E Ratio394.0
ROE0.25%
ROA-0.99%
Debt/Equity0.99
P/B Ratio2.3
Op. Cash Flow$149.3M
Free Cash Flow$116.2M
Industry P/E38.2

Technical Analysis

TrendNeutral
RSI41.4
Support$3.77
Resistance$4.64
MA 20$4.22
MA 50$4.13
MA 200$4.76
MACDBearish
VolumeIncreasing
Fear & Greed Index89.04

Valuation

Fair Value$9.47
Target Price$5.19
Upside/Downside31.75%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.82
Volatility43.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.